Latest News about Briefs
Recent news which mentions Briefs
Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Today 3:30 EST
From Benzinga
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
November 01, 2024
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
November 01, 2024
From Benzinga
Shell Reports Strong Q3: Analysts Highlight Robust Buybacks Amid Market Challenges
November 01, 2024
From Benzinga
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
November 01, 2024
From Benzinga
ConocoPhillips-Marathon Synergy Will Boost Free Cash Flow And Stock Buyback: Analyst
November 01, 2024
From Benzinga
Uber's Q3 Review: Analysts See Opportunity Amid Growth Slowdown, Strong Margins, And Expanding Autonomous Vehicle Partnerships
November 01, 2024
From Benzinga
What's Going On With Rivian Stock Today?
November 01, 2024
From Benzinga
From Benzinga
Apple Satellite Connectivity Provider Globalstar Stock Surges After Deal Extension
November 01, 2024
From Benzinga
What's Going On With Taiwan Semiconductor and ASML Stocks On Friday?
November 01, 2024
From Benzinga
Phoenix Motor Drops Despite Revenue Surge, New EV Contracts
November 01, 2024
From Benzinga
Why Is Infrastructure Construction Company MasTec Stock Surging Today?
November 01, 2024
From Benzinga
Church & Dwight Surpasses Q3 Expectations: Strong Sales Growth And Brand Investments Fuel Gains
November 01, 2024
From Benzinga
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
November 01, 2024
From Benzinga
LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4
November 01, 2024
From Benzinga
From Benzinga
From Benzinga
Nvidia's Run:ai Acquisition Draws European Regulatory Scrutiny On Competition Concerns
November 01, 2024
From Benzinga
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
November 01, 2024
From Benzinga
FuboTV Q3 Earnings: Subscribers Grow 9% To 1.61 Million, Narrows EPS Loss, Raises Annual Outlook
November 01, 2024
From Benzinga
Dominion Energy Q3 Results: Revenue Miss, Earnings Beat, And Updated FY24 Guidance
November 01, 2024
From Benzinga
ArcBest Shares Fall On Q3 Revenue Miss, Productivity Gains Can't Offset Shipment Decline
November 01, 2024
From Benzinga
Charter Communications Beats Q3 Estimates On Strong Mobile Growth, Expanding Margins
November 01, 2024
From Benzinga
Cardinal Health Raises 2025 Profit Outlook Again, Helped By Strong Drug Distribution Business
November 01, 2024
From Benzinga
Exxon Q3 Earnings: $11.3 Billion Cost Savings, Rising Production, Dividend Hike And More
November 01, 2024
From Benzinga
Chevron Q3 Earnings: Production Boost By PDC Energy & Permian Basin, Targets $2-$3 Billion In Structural Savings By 2026
November 01, 2024
From Benzinga
Asia In Red, Europe Markets Gain; Crude Oil Rises 2.5% - Global Markets Today While US Slept
November 01, 2024
From Benzinga
Ford To Halt F-150 EV Production For 7 Weeks Next Month
October 31, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.